28-10-2025 16:38 via cbc.ca

Drug to slow early-stage Alzheimer's disease approved by Health Canada

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer's disease.

Read more »

Vaccine records aren't up-to-date for more than half of Ottawa, Toronto students assessed: public health

Ornge takes on average just under 4 hours to reach critically ill patients in northern Ontario, inquest told

Doctors in Montreal can now prescribe their patients tickets to the orchestra

Frustration over Sask. emergency room closures drives change to notifications

Province has gained doctors but is having trouble keeping them, Doctors Manitoba says

Manitoba has gained doctors but is having trouble keeping them, Doctors Manitoba says

How some Canadian families are making trick-or-treating more accessible

Cost estimate more than triples to $1.3B for new federal inmate hospital

1 minute of silence: Inside the Quebec ER that cared for abandoned newborn who died

Quebec's pain, Ontario and N.B.'s gain? Doctors look to leave province over new forced deal

Avian flu found on 5 commercial poultry farms in Manitoba, culls now underway

What we know about the Alzheimer's drug Health Canada approved

Doctor didn’t do rigorous check of emaciated boy days before death, Ont. trial for 2 prospective parents told

More Alberta parents pushing back against vitamin K injection for newborns, some doctors say